Received 11 March 2010 | Accepted 25 June 2010 | Published 30 June 2010
The first three authors contribute equally to the work
1Biomedical Engineering Center, Fujian Medical University, Fuzhou, Fujian, China; 2Department of Genetics, National Research Institute for Family Planning, Peking Union Medical College, Beijing, China; 3Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China; 4Fuzhou Southeast Eye Hospital, Fuzhou, Fujian, China; 5Department of Ophthalmology, The First Hospital of Xi'an, Xi’an, Shanxi, China; 6Department of Ophthalmology, Affiliated Hospital of Jining Medical college, Jining, Shandong,China; 7Department of Ophthalmology, Jianou City Hospital, Jianou, Fujian, China
Correspondence to: Professor Xu Ma, Department of Genetics, National Research Institute for Family Planning, Peking Union Medical College, 12 Da-hui-si, Hai Dian, Beijing, China, 100081; Phone: +86 1062179059; FAX: +86 10 62179059; email: email@example.com
Purpose: To analyze human transforming growth factor b-induced (TGFBI) gene mutations in Chinese patients with corneal dystrophies (CDs).
Methods: Twenty-one families with corneal dystrophies were subjected to phenotypic and genotypic characterization. The corneal phenotypes of patients were documented by slit lamp photography. Mutation screening of the coding regions of TGFBI was performed by direct sequencing. An additional 43 families and 3 sporadic patients with TGFBI dystrophies from China reported in the literature were reviewed.
Results: Five mutations of TGFBI were identified in 21 families with CDs, including one novel small deletion mutation, c.△1838–1849 (p.Δ613–616VAEP), responsible for one variant lattice CD (LCD) family and 4 known mutations, R555W mutation for 10 granular cornea dystrophy type I (GCD1) families, R124H for 5 GCD type II (GCD2), R124C for 4 LCD1, and H626R for one variant LCD. In a cohort of Chinese patients (n=355) with TGFBI dystrophies from 64 families and 3 sporadic cases, 19 distinct mutations were found in several different CD subtypes. The 3 most common phenotypes were ranked as follows: GCD1, GCD2, and LCD1. Mutation hot spots at R124 and R555 occurred in >80% of these families.
Conclusions: Our findings extend the mutational spectrum of TFGBI, and this is also the first extensively delineated TGFBI mutation profile associated with the various corneal dystrophies in the Chinese population.
Corneal dystrophies (CDs) are characterized by the occurrence of bilateral progressive opacities of the cornea that often arise from the deposition of insoluble material in the corneal stroma and lead to visual impairment. Since 1997, multiple phenotypes have been identified that are related to allelic mutations of the human transforming growth factor b-induced (TGFBI) gene (OMIM 601692) on human chromosome 5q31 . This gene, originally named beta-ig-h3 (BIGH3), comprises 17 exons coding for a unique protein of 683-amino acids, which is produced by both mesenchymal and epithelial cells and denoted as keratoepithelin . At present, more than 50 distinct disease-causing mutations have been identified in TFGBI that are associated with different corneal dystrophies, including granular cornea dystrophy (GCD) type I (GCD1; OMIM 121900), GCD type II (GCD2; OMIM 607541), lattice corneal dystrophy type I(LCD1; OMIM 122200), variant LCD, Thiel-Behnke corneal dystrophy (CDTB; OMIM 602082), Reis-Buckler corneal dystrophy (CDRB; OMIM 608470), and epithelial basement membrane corneal dystrophy (EBMD; OMIM 121820). In the present study, we designated all of the cornea dystrophies associated with TGFBI mutations as TGFBI dystrophies.
Of these mutations, two mutational hot spots have been identified corresponding to R124 and R555 of the TGFBI protein as being the most frequent sites of mutation in various populations [2-7]. Despite TGFBI dystrophies represent a clinically heterogeneous group of disorders, a strong correlation between specific mutations at these two positions and the observed phenotypes has been observed: GCD1/R555W, CDTB/R555Q, LCD1/R124C, GCD2/R124H, and CDRB/R124L. These above CDs were also classified as the classic form of TGFBI dystrophies .
The TGFBI mutation spectrum and their clinical consequences have been investigated in patients with CDs in different ethnic populations [2-7]. However, the spectrum of TGFBI mutations and the correlation between genotype and phenotype in the Chinese population has not been studied extensively. In this study, we report our findings on 21 new CD families with TGFBI mutations, and an additional 43 families and 3 sporadic patients with TGFBI dystrophies in a Chinese population collected from the literature [9-31], and delineate extensively the TGFBI mutation profile associated with the various corneal dystrophies in China.
As part of a genetic screening program for genetic eye disorders, we collected materials from 26 families diagnosed with corneal dystrophies from China. A slit-lamp examination was performed for all participating individuals to determine if they were affected or unaffected with corneal dystrophies and to determine the disease phenotype. Of these families, 21 were further classified into 3 diagnostic categories: GCD1 in 10 families, LCD in 6 families, and GCD2 in 5 families. The pedigrees of these 21 families are shown in Figure 1, and the slit-lamp photographs of the representative patients with CDs are shown in Figure 2. After informed consent conforming to the tenets of the Declaration of Helsinki and following the guidance of sample collection of National Infrastructure Program of Chinese Genetic Resources (NICGR), 112 blood samples (58 samples from patients and 54 from normal members of families) from the 21 families and other 50 samples from ethnically matched control individuals were obtained before the study.
Total genomic DNA was extracted from whole blood using the Wizard Genomic DNA Purification Kit (Promega, Beijing, China) according to the manufacturer’s instructions. Amplification of the coding regions of TGFBI from genomic DNA was performed with the primers as described previously [1,2,22]. The sequences of the primers are listed in Table 1. Each PCR reaction was carried out in a 50 µl reaction mixture containing 100-200 ng of genomic DNA, 0.25 µl of TaKaRa Ex TaqTM (5U/µl; TaKaRa Biotechnology Co., Ltd., Dalian, China), 4.0 µl of dNTPs (2.5 mM each), 1.0 µl of each primer (10 pmol), 5 µl of 10× Ex Taq Buffer (Mg2+ plus). PCR conditions were as follows: 94 °C for 3 min; 30 cycles of 94 °C for 30 s, 52 °C or 55 °C or 58 °C for 30 s, 72 °C for 1 min; and further extension step at 72 °C for 5 min. PCR products were purified and sequenced on an ABI 3730XL Automated Sequencer (PE Biosystems, Foster City, CA), using the same PCR forward primers.
To evaluate the incidence of TFGBI mutations in Chinese patients with TGFBI dystrophies, we also reviewed published articles obtained by an electronic search on PubMed/MEDLINE, VIP Information, CNKI, WANGFANG, data and Google using the keywords “corneal dystrophy” and “TGFBI” or “BIGH3.” Articles were limited to full papers in the English or Chinese language literature, and the search ended in February, 2010. When the same author reported results obtained on a complete or partial similar patient population in several publications, only the most recent or the most complete report was included in the analysis to avoid overlap. According to these criteria, 23 eligible trials published between 2002 and 2010 were selected [9-31]. The articles reported mutations of the TGFBI/BIGH3 gene associated with corneal dystrophies in the Chinese population. All of these TGFBI dystrophies were reclassified as classic or variant form according to Aldave and Sonmez’s  criterion.
We screened the coding regions of TGFBI using PCR-based ampliﬁcation followed by direct sequencing. Mutations were identified in all patients from the 21 unrelated Chinese families (Figure 1). Five distinct mutations of TGFBI were identified, including one novel small deletion mutation, c.Δ1838–1849 (p.Δ613–616VAEP), in exon 14 responsible for the HCD-022 family with variant LCD (Figure 1E and Figure 2I). This mutation was found in the proband and her son, but not in her parents and 50 normal controls. The other four known mutations were R555W mutation for 10 GCD1 families (Figure 1A and Figure 2A-C), R124H for 5 GCD2 families (Figure 1B and Figure 2D), R124C for 4 LCD1 families (Figure 1C and Figure 2G) and H626R for one variant LCD family (Figure 1D and Figure 2H).
To delineate the TGFBI mutation profile associated with the various corneal dystrophies in the Chinese population, an additional 43 families and 3 sporadic cases with TGFBI dystrophies collected from the literature were also included in the investigation. Thus, a total of 355 patients from 64 families and 3 sporadic patients were included in the statistical analysis. We reclassified these TGFBI dystrophies as classic or variant form, with GCD1/R555W, GCD2/R124H, LCD1/R124C, CDRB/R124L, and CDTB/R555Q as classic forms and the others as corresponding variants .
In this cohort of Chinese patients, 19 distinct TGFBI mutations were identified in several different CD subtypes (Table 2). The most common phenotypes were the GCD1 associated with the R555W mutation (26.6%, 17/64 families), GCD2 with the R124H mutation (26.6%,17/64families), and LCD1 with the R124C mutation (18.8%,12/64 families). The mutational hot spots at positions R124 and R555 occurred in 53.1% (34/64) and 28.1% (18/64) of the families, respectively. Our observation also showed that the phenotypes correlated strongly with specific mutations in TGFBI, including that between GCD1 and R555W, GCD2 and R124H, and LCD1 and R124C. The exception is two CDTB families associated with the R124C mutation . In addition, more than half (11/19) of these mutations were observed in Chinese patients with variant LCDs (Table 2).
We searched for mutations of TGFBI in 21 unrelated Chinese families affected with GCDs or LCDs. Five distinct mutations of TGFBI were identified in all of the families (Figure 1), and there have been perfect correlations between GCD1 and R555W, between GCD2 (ACD) and R124H, and between LCD1 and R124C. Among of these mutations, one novel 12 bp deletion mutation, c.Δ1838–1849 (p.Δ613–616VAEP), in exon 14 was found in the HCD-022 family (Figure 1E) with variant LCD (Figure 2I). Compare with the five small deletion mutations (1~6 bp deleted) in TGFBI reported previously by other groups [2,4,9,32,33], this mutation was the longest deletion mutation in TGFBI. It was also identified as a spontaneous inheritable TGFBI mutation because only the proband and her affected son carried the mutation, and not her parents. Spontaneous mutations in this gene are rare, but have been reported. Tanhehco et al.  reported a spontaneous R124L mutation in TGFBI in 2 patients with CDRB, and Zhao et al.  reported a spontaneous R555Q mutation in TGFBI in two unrelated families with Bowman's layer corneal dystrophies (CDTB and CDRB). Our finding not only extends the mutational spectrum of TFGBI, but also has historic value as a possible explanation for the presence of this autosomal dominant disorder in the population.
Through extensive investigation of the clinical and genetic findings in TGFBI dystrophies in the Chinese population, we observed that GCD1 in association with the R555W mutation (17 families) and GCD2 in association with the R124H mutation (17 families) accounted for more than half (53.1%, 34/64) of the families and were the most prevalent type of this disease. Our observations also confirm the presence of mutation hot spots at positions R124 and R555, which occur in more than 80% (52/64) of the families with TGFBI dystrophies in China. There were strong genotype-phenotype correlations between R555W and GCD1, between R124H and GCD2, and between R124C and LCD1 in our collection of 64 families, which is consistent with previous reports in patients from other ethnic origins [2-7]. The exception is 2 Chinese typical CDTB families associated with the R124C mutation . Although these two mutations have been identified as major causes of LCDs or GCDs in different ethnic groups [2-7], population-specific variations in the prevalence of different mutations in TGFBI have been documented. The classic form of GCD1 with the R555W mutation and LCD1 with the R124C mutation are more common in different ethnic groups in Europe, the United States, and India [2,4,6,7], but in other populations, such as in Japan and Korea, GCD1 is found much less frequently than GCD2 associated with the R124H mutation [3,5], and H626R may be more frequent than R124C in Vietnamese patients with LCDs .
The second common type of TGFBI dystrophies is the LCDs, which accounted for more than one third of all of the families (34.4%, 22/64) in the Chinese population. Of these LCDs families, the major subtype is the classic form of LCD (LCD1) associated with the R124C mutation (54.5%,12/22). The other different forms of lattice dystrophy were reclassified as variant LCDs, which were the most mutationally heterogeneous and accounted for half of the mutations identified. In comparison to these common types, CDRB and CDTB were rare (about 5% of each subtype) in the Chinese population.
Most of the TGFBI mutations associated with corneal dystrophies are heterozygous. However, homozygous mutations are also found in some patients with severe form of TGFBI dystrophies [37,38]. Only two patients bearing homozygous R124H mutations from a consanguineous marriage family with GCD2 have been reported in China . This disease is also described as a semidominant condition in which the heterozygous mutant is less severely affected than the homozygote. We also found a patient with severe form of corneal dystrophy in a consanguineous marriage family clinically diagnosed as GCD2. He had confluent round opacities in a coralloid shape in both of his eyes (Figure 2E), which is similar in phenotype to the patients with GCD2 bearing a homozygous R124H mutation reported previously . His parents and brother had fewer round opacities and spicular opacities (Figure 2F). Unfortunately, we could not obtain blood samples for gene examination.
In addition to allelic heterogeneity, TGFBI dystrophies also exhibited extensive intrafamily and interfamily variations in clinical phenotypes, even when the same single point mutation in TGFBI is involved. Perhaps the most extreme example of the phenotypic variability is unaffected carriers who had the disease-causing mutations in TGFBI. In our collection of 64 Chinese families, 11 these carriers from 4 families were reported [21,23,24]. Of these cases, 2 unaffected relatives bearing the A546D mutation from a GCD1 family  and 2 from 2 LCD1 families carrying the R124C mutation  were too young to rule out inheritance of these two diseases by clinical examination. However, 7 individuals carrying a heterogeneous R124H mutation showed no clinical manifestations in a reduced penetrance GCD2 Chinese family, and an age-related factor was excluded in the contribution to these carriers . All of this clinical evidence suggests that other factors such as age, environmental factors, and modifier genes may influence the expressivity and the penetrance of this disease, but further studies are needed for confirmation.
In summary, this study reported our findings in 21 new CD families with TGFBI mutations, and delineated extensively the TGFBI mutation profile associated with the various corneal dystrophies in the Chinese population: both GCD1 associated with the R555W mutation and GCD2 with the R124H mutation are the most common forms of this disease. We also confirmed the presence of mutational hotspots at positions R124 and R555, and a strong correlation between these two mutations and their phenotypes.
The authors thank all patients and their family members for taking part in this study. This work was supported by the National Infrastructure Program of Chinese Genetic Resources (2006DKA21301), National Science & Technology Pillar Program of China (2008BAH24B05), National Natural science Foundation of China (30872843), Natural Science Foundation of Fujian Province (C0810018), the Key Program of Scientific Research of Fujian Medical University(09ZD016–1), and Program for New Century Excellent Talents in Fujian Province University (Juhua Yang). Professor Xu Ma (firstname.lastname@example.org) and Dr. Juhua Yang (email@example.com) contributed equally to the research presented and can be considered as co-corresponding authors.